Ahmed El-Balat

5PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 12, 2026
The Role of Chlorhexidine Gluconate (ChloraPrep™) in Reducing Surgical Site Infections After Ovarian Cancer Surgery.

|Dec 03, 2025
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial.

Philipp Harter, Frederik Marmé, Andrés Redondo

|Nov 04, 2022
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.

Jacobus Pfisterer, Florence Joly, Gunnar Kristensen

|Jan 04, 2020
Histotype-specific analysis of acid ceramidase expression in ovarian cancer.

Ahmed El-Balat, Thomas Karn, Uwe Holtrich

|Sep 02, 2018
Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovary.

Ahmed El-Balat, Iryna Schmeil, Khayal Gasimli

Pageof 1

Frequent Collaborators

2 joint publications

Florence Joly

2 joint publications

Annette Hasenburg

2 joint publications

Philipp Harter

1 joint publications

Thomas Karn